Natural Product: NPC488885

Natural Product IDNPC488885
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
BGSMAWFQONMDSF-ADTLDIINSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey BGSMAWFQONMDSF-ADTLDIINSA-N
Standard InCHI InChI=1S/C122H84O78/c123-40-1-25(2-41(124)70(40)143)104(166)189-97-95-62(23-181-111(173)32-15-52(135)77(150)85(158)64(32)66-34(113(175)187-95)17-54(137)79(152)87(66)160)185-119(196-108(170)29-9-48(131)74(147)49(132)10-29)100(97)194-117(179)38-21-58(141)83(156)91(164)93(38)183-60-13-30(11-50(133)75(60)148)109(171)197-120-101(98(190-105(167)26-3-42(125)71(144)43(126)4-26)96-63(186-120)24-182-112(174)33-16-53(136)78(151)86(159)65(33)67-35(114(176)188-96)18-55(138)80(153)88(67)161)195-118(180)39-22-59(142)84(157)92(165)94(39)184-61-14-31(12-51(134)76(61)149)110(172)198-121-102(192-107(169)28-7-46(129)73(146)47(130)8-28)99(191-106(168)27-5-44(127)72(145)45(128)6-27)103-122(200-121)199-116(178)37-20-57(140)82(155)90(163)69(37)68-36(115(177)193-103)19-56(139)81(154)89(68)162/h1-22,62-63,95-103,119-165H,23-24H2/t62-,63-,95-,96-,97+,98+,99-,100-,101-,102-,103+,119+,120+,121-,122+/m1/s1
SMILES c1c(cc(c(c1O)O)O)C(=O)O[C@H]1[C@H]2[C@@H](COC(=O)c3cc(c(c(c3-c3c(cc(c(c3O)O)O)C(=O)O2)O)O)O)O[C@H]([C@@H]1OC(=O)c1cc(c(c(c1Oc1cc(cc(c1O)O)C(=O)O[C@H]1[C@@H]([C@H]([C@H]2[C@@H](COC(=O)c3cc(c(c(c3-c3c(cc(c(c3O)O)O)C(=O)O2)O)O)O)O1)OC(=O)c1cc(c(c(c1)O)O)O)OC(=O)c1cc(c(c(c1Oc1cc(cc(c1O)O)C(=O)O[C@H]1[C@@H]([C@H]([C@H]2[C@@H](OC(=O)c3cc(c(c(c3-c3c(cc(c(c3O)O)O)C(=O)O2)O)O)O)O1)OC(=O)c1cc(c(c(c1)O)O)O)OC(=O)c1cc(c(c(c1)O)O)O)O)O)O)O)O)O)OC(=O)c1cc(c(c(c1)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   2796.26 Volume:   2466.431
?
Van der Waals volume.
Dense:   1.134 LogP:   -1.225
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   -3.059
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -6.066
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   31.0 Rigid Bonds:   146.0
TPSA:   1310.54
?
Topological Polar Surface Area.
H-Bond Acceptor:   78.0
H-Bond Donor:   43.0 Rings:   21.0
Heavy Atoms:   78.0

MedChem Properties

QED Drug-Likeness Score:   0.022 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   9.15 Fsp3:   0.139
MCE-18:   522.381
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   1.0 Fluc inhibitor:   0.1
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.35
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.667
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.844 Promiscuous compounds:   0.962

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -12.26 MDCK Permeability:   -4.035
Pgp-inhibitor:   0.0 Pgp-substrate:   0.0
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   1.0
Plasma Protein Binding (PPB):   70.009% Volume Distribution (VD):   0.037
Fu: 5.306%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.996
OATP1B3 inhibitor:   0.721 BCRP inhibitor:   0.011
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   1.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.576 Half-life (T1/2):  14.878

ADMET: Toxicity

hERG Blockers:  0.0 hERG Blockers (10um):  1.0
Human Hepatotoxicity (H-HT):  0.004 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  1.0 Rat Oral Acute Toxicity:  0.0
Maximum Recommended Daily Dose:  0.999 Skin Sensitization:  1.0
Carcinogencity:  0.001 Eye Corrosion:  0.0
Eye Irritation:  0.004 Respiratory Toxicity:  0.0
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  1.0
Hematotoxicity:  0.0 Drug-induced Nephrotoxicity:  0.0
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.0
A549 Cytotoxicity:  1.0 Hek293 Cytotoxicity:  0.796
BCF:   -2.566
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.082
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   3.632
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.358
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. PMID[20405847]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. PMID[23675651]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota Leaves n.a. n.a. PMID[26938659]
NPO20786 Tamarix tetrandra Species Tamaricaceae Eukaryota Leaves n.a. n.a. PMID[26938659]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO20786 Tamarix tetrandra Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO20786 Tamarix tetrandra Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell line HL-60 Homo sapiens CC50 = 9390.0 nM PMID[26938659]
NPT2394 Cell line HSC-4 Homo sapiens CC50 = 38200.0 nM PMID[26938659]
NPT2385 Cell line HSC-3 Homo sapiens CC50 = 37400.0 nM PMID[26938659]
NPT924 Cell line HSC-2 Homo sapiens CC50 = 18700.0 nM PMID[26938659]
NPT2 Others Unspecified n.a. CC50 > 100000.0 nM PMID[26938659]
NPT2 Others Unspecified n.a. CC50 = 87300.0 nM PMID[26938659]
NPT2 Others Unspecified n.a. CC50 = 96000.0 nM PMID[26938659]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC488885 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9268 High Similarity NPC488884
0.9221 High Similarity NPC223534
0.9 High Similarity NPC187632
0.9 High Similarity NPC240200
0.8831 High Similarity NPC40078
0.878 High Similarity NPC194439
0.878 High Similarity NPC33724
0.8395 Intermediate Similarity NPC290289
0.8276 Intermediate Similarity NPC488887
0.8276 Intermediate Similarity NPC488886
0.8272 Intermediate Similarity NPC483712
0.8272 Intermediate Similarity NPC158214
0.8272 Intermediate Similarity NPC214202
0.8049 Intermediate Similarity NPC97924
0.7912 Intermediate Similarity NPC469652
0.7912 Intermediate Similarity NPC486025
0.7912 Intermediate Similarity NPC486024
0.7805 Intermediate Similarity NPC112211
0.7805 Intermediate Similarity NPC254925
0.7742 Intermediate Similarity NPC93065
0.7742 Intermediate Similarity NPC220876
0.7579 Intermediate Similarity NPC31208
0.7579 Intermediate Similarity NPC160543
0.7263 Intermediate Similarity NPC260521
0.7174 Intermediate Similarity NPC471091
0.7172 Intermediate Similarity NPC174140
0.7105 Intermediate Similarity NPC469651
0.7021 Intermediate Similarity NPC469649
0.6974 Remote Similarity NPC43918
0.6974 Remote Similarity NPC261411
0.6974 Remote Similarity NPC190204
0.6842 Remote Similarity NPC47521
0.6421 Remote Similarity NPC116108
0.5699 Remote Similarity NPC269625
0.5584 Remote Similarity NPC114791
0.5584 Remote Similarity NPC104222
0.5584 Remote Similarity NPC210501
0.5584 Remote Similarity NPC318826
0.5584 Remote Similarity NPC141331
0.5465 Remote Similarity NPC149300
0.5333 Remote Similarity NPC8940
0.5098 Remote Similarity NPC189312
0.5046 Remote Similarity NPC201814

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC488885 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data